VIR icon

Vir Biotechnology
VIR

Overview Fund Activity

223 hedge funds and large institutions have $2.18B invested in Vir Biotechnology in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 81 increasing their positions, 74 reducing their positions, and 25 closing their positions.

Holders
223
Holders Change
+4
Holders Change %
+1.83%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
34
Increased
81
Reduced
74
Closed
25
Calls
$5.69M
Puts
$3.15M
Net Calls
+$2.54M
Net Calls Change
+$2.11M

Top Buyers

1
Pacer Advisors
1
Pacer Advisors
Pennsylvania
$27.8M
2
APM
2
Avidity Partners Management
Texas
$21.5M
3
American Century Companies
3
American Century Companies
Missouri
$26.7M
4
Skandinaviska Enskilda Banken (SEB)
4
Skandinaviska Enskilda Banken (SEB)
Sweden
$11.2M
5
BlackRock
5
BlackRock
New York
$358M

Top Sellers

1
SIAU
1
SB Investment Advisers (UK)
United Kingdom
$513M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$26.8M
3
State Street
3
State Street
Massachusetts
$139M
4
Temasek Holdings
4
Temasek Holdings
Singapore
$145M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CM
251
Caption Management
Oklahoma
– – – –
CG
252
Cutler Group
California
– – – –
CFGS
253
Concourse Financial Group Securities
Alabama
– – – –
HT
254
HAP Trading
New York
– – – –
7 8 9 10
11